PT1590467E - Utilização de sequências reguladoras para expressão específica transiente em células determinadas neuronais - Google Patents
Utilização de sequências reguladoras para expressão específica transiente em células determinadas neuronais Download PDFInfo
- Publication number
- PT1590467E PT1590467E PT04705802T PT04705802T PT1590467E PT 1590467 E PT1590467 E PT 1590467E PT 04705802 T PT04705802 T PT 04705802T PT 04705802 T PT04705802 T PT 04705802T PT 1590467 E PT1590467 E PT 1590467E
- Authority
- PT
- Portugal
- Prior art keywords
- neuronal
- cells
- regulatory sequences
- methods
- transient expression
- Prior art date
Links
- 230000001537 neural effect Effects 0.000 title abstract 7
- 230000001105 regulatory effect Effects 0.000 title abstract 6
- 230000010474 transient expression Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 5
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 230000009261 transgenic effect Effects 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 2
- 230000004031 neuronal differentiation Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 230000004766 neurogenesis Effects 0.000 abstract 1
- 230000017511 neuron migration Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03002027 | 2003-01-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1590467E true PT1590467E (pt) | 2010-01-05 |
Family
ID=32798732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT04705802T PT1590467E (pt) | 2003-01-28 | 2004-01-28 | Utilização de sequências reguladoras para expressão específica transiente em células determinadas neuronais |
Country Status (8)
Country | Link |
---|---|
US (4) | US20070107071A1 (pt) |
EP (1) | EP1590467B1 (pt) |
AT (1) | ATE446371T1 (pt) |
DE (1) | DE602004023692D1 (pt) |
DK (1) | DK1590467T3 (pt) |
ES (1) | ES2334231T3 (pt) |
PT (1) | PT1590467E (pt) |
WO (1) | WO2004067751A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10339727A1 (de) * | 2003-08-22 | 2005-03-17 | Max-Delbrück-Centrum für Molekulare Medizin | Verfahren zur Bestimmung der adulten Neurogenese |
CN1989244B (zh) | 2004-02-09 | 2013-04-03 | 柏格丹由里 | 用于治疗cns病症的tgf-r信号传递抑制剂 |
US20090055941A1 (en) | 2005-03-22 | 2009-02-26 | Agency For Science, Technology And Research | Novel Neural Cell Specific Promoter And Baculovirus And Method For Gene Delivery |
WO2006128149A1 (en) * | 2005-05-26 | 2006-11-30 | Lexicon Genetics Incorporated | Methods and compositions for defining gene function |
US20110296540A1 (en) * | 2008-12-03 | 2011-12-01 | Rene Hen | Assay for screening antidepressants |
EP2449112A1 (en) | 2009-07-01 | 2012-05-09 | Transposagen Biopharmaceuticals, Inc. | Genetically modified rat models for severe combined immunodeficiency (scid) |
US20110135613A1 (en) * | 2009-12-03 | 2011-06-09 | The J. David Gladstone Institutes | Methods for treating apolipoprotein e4-associated disorders |
EP2330418A1 (en) | 2009-12-04 | 2011-06-08 | SYGNIS Bioscience GmbH & Co KG | Methods of quantitative determination of neurogenesis in vivo |
US9074222B2 (en) * | 2013-01-25 | 2015-07-07 | The University Of British Columbia | DCX mini-promoters |
JP2016523125A (ja) | 2013-05-30 | 2016-08-08 | グラハム エイチ. クリーシー | 局所神経性刺激 |
US11229789B2 (en) | 2013-05-30 | 2022-01-25 | Neurostim Oab, Inc. | Neuro activator with controller |
CN106062182A (zh) * | 2014-01-17 | 2016-10-26 | 住友化学株式会社 | 用于制备睫状缘干细胞的方法 |
MX2017005186A (es) * | 2014-10-20 | 2017-07-26 | Neuralstem Inc | Celulas madre neurales estables que comprenden un polinucleótido exógeno que codifica un factor de crecimiento y métodos de uso de las mismas. |
US11077301B2 (en) | 2015-02-21 | 2021-08-03 | NeurostimOAB, Inc. | Topical nerve stimulator and sensor for bladder control |
WO2018026517A1 (en) * | 2016-08-04 | 2018-02-08 | Exxonmobil Research And Engineering Company | Increasing scales, capacities, and/or efficiencies in swing adsorption processes with hydrocarbon gas feeds |
TWI808079B (zh) | 2017-04-03 | 2023-07-11 | 美商編碼製藥公司 | 組織選擇性轉基因表現 |
CA3082390C (en) | 2017-11-07 | 2023-01-31 | Neurostim Oab, Inc. | Non-invasive nerve activator with adaptive circuit |
JP2022538419A (ja) | 2019-06-26 | 2022-09-02 | ニューロスティム テクノロジーズ エルエルシー | 適応回路を備えた非侵襲性神経活性化装置 |
CA3152451A1 (en) | 2019-12-16 | 2021-06-24 | Michael Bernard Druke | Non-invasive nerve activator with boosted charge delivery |
JP2023517230A (ja) * | 2020-03-11 | 2023-04-24 | リモーター セラピューティクス インコーポレイテッド | 中枢神経系全体にわたってタンパク質を散在させるための方法および材料 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2861892A (en) | 1991-10-04 | 1993-05-03 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Astrocyte-specific transcription of human genes |
US5661032A (en) | 1994-03-18 | 1997-08-26 | Mcgill University | Tα1 α-tubulin promoter and expression vectors |
US6245564B1 (en) | 1997-01-23 | 2001-06-12 | Cornell Research Foundation, Inc. | Method for separating cells |
EP0918091A1 (en) * | 1997-11-21 | 1999-05-26 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | A gene called XLIS and the XLIS gene product, called doublecortin and their applications |
US8263402B1 (en) | 1998-10-19 | 2012-09-11 | Cornell Research Foundation, Inc. | Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells |
US7785882B2 (en) | 2000-01-18 | 2010-08-31 | Cornell Research Foundation, Inc. | Neuronal progenitor cells from hippocampal tissue and a method for isolating and purifying them |
-
2004
- 2004-01-28 US US10/543,713 patent/US20070107071A1/en not_active Abandoned
- 2004-01-28 DK DK04705802.9T patent/DK1590467T3/da active
- 2004-01-28 EP EP04705802A patent/EP1590467B1/en not_active Expired - Lifetime
- 2004-01-28 WO PCT/EP2004/000760 patent/WO2004067751A1/en active Application Filing
- 2004-01-28 PT PT04705802T patent/PT1590467E/pt unknown
- 2004-01-28 DE DE602004023692T patent/DE602004023692D1/de not_active Expired - Lifetime
- 2004-01-28 ES ES04705802T patent/ES2334231T3/es not_active Expired - Lifetime
- 2004-01-28 AT AT04705802T patent/ATE446371T1/de active
-
2008
- 2008-09-12 US US12/209,974 patent/US7947448B2/en not_active Expired - Lifetime
-
2010
- 2010-09-30 US US12/894,766 patent/US8841430B2/en active Active
- 2010-09-30 US US12/894,884 patent/US8815505B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP1590467A1 (en) | 2005-11-02 |
US20090170099A1 (en) | 2009-07-02 |
ES2334231T3 (es) | 2010-03-08 |
US7947448B2 (en) | 2011-05-24 |
DK1590467T3 (da) | 2010-01-18 |
US20110016547A1 (en) | 2011-01-20 |
US8841430B2 (en) | 2014-09-23 |
US20110020790A1 (en) | 2011-01-27 |
ATE446371T1 (de) | 2009-11-15 |
WO2004067751A1 (en) | 2004-08-12 |
EP1590467B1 (en) | 2009-10-21 |
DE602004023692D1 (de) | 2009-12-03 |
US8815505B2 (en) | 2014-08-26 |
US20070107071A1 (en) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1590467E (pt) | Utilização de sequências reguladoras para expressão específica transiente em células determinadas neuronais | |
Singh | Mitochondria damage checkpoint, aging, and cancer | |
Gerdes | The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations | |
Pehrson et al. | Mice without macroH2A histone variants | |
Landry et al. | Found in translation: functions and evolution of a recently discovered alternative proteome | |
Kim et al. | Proteomic analysis of cadmium-induced protein profile alterations from marine alga Nannochloropsis oculata | |
Ma et al. | iTRAQ-based quantitative proteomics analysis of the spleen reveals innate immunity and cell death pathways associated with heat stress in broilers (Gallus gallus) | |
Gan et al. | FIP200, a key signaling node to coordinately regulate various cellular processes | |
Ross et al. | Voluntary exercise normalizes the proteomic landscape in muscle and brain and improves the phenotype of progeroid mice | |
Suzuki et al. | Identical sets of methylated and nonmethylated genes in Ciona intestinalis sperm and muscle cells | |
Alvarez et al. | The stoichiometric transition from Zn6Cu1-metallothionein to Zn7-metallothionein underlies the up-regulation of metallothionein (MT) expression: quantitative analysis of MT-metal load in eye cells | |
Leman et al. | 3D-organotypic cultures to unravel molecular and cellular abnormalities in atopic dermatitis and ichthyosis vulgaris | |
Liu et al. | Genetic signatures of high-altitude adaptation and geographic distribution in Tibetan sheep | |
WO2005047469A3 (en) | PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION | |
Xiao et al. | Analysis of skin and secretions of Dybowski’s frogs (Rana dybowskii) exposed to Staphylococcus aureus or Escherichia coli identifies immune response proteins | |
Cole et al. | Enzyme polymorphisms in the house sparrow, Passer domesticus | |
Yin et al. | Tyrosinase-mediated melanogenesis in melanoma cells: Array comparative genome hybridization integrating proteomics and bioinformatics studies | |
Moral-Sanz et al. | ERK and mTORC1 inhibitors enhance the anti-cancer capacity of the octpep-1 venom-derived peptide in melanoma BRAF (V600E) mutations | |
NO20021146L (no) | Polymorfier i det humane CYP3A7 og CYP3A7 gener og deres anvendelse i diagnostikk og terapeutiske applikasjoner | |
Bekpen et al. | Involvement of SPATA31 copy number variable genes in human lifespan | |
Sun et al. | Proteomic analysis of the skin from Chinese fire-bellied newt and comparison to Chinese giant salamander | |
Taraslia et al. | Proteomic analysis of normal murine brain parts | |
Grant et al. | How a host cell signalling molecule modifies carbon metabolism in symbionts of the coral Plesiastrea versipora | |
Shamir et al. | Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder | |
Zalomaeva et al. | Effects of weak static magnetic field and oligopeptides on cell proliferation and cognitive functions in different animal species |